{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:54:50Z","timestamp":1752231290676},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"DOI":"10.1007\/s11657-023-01321-y","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T07:02:26Z","timestamp":1693983746000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A diagnostic predictive model for secondary osteoporosis in patients with fragility fracture: a retrospective cohort study in a tertiary care hospital"],"prefix":"10.1007","volume":"18","author":[{"given":"Pitchaporn","family":"Phudphong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattabhorn","family":"Phimphilai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Worapaka","family":"Manosroi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nath","family":"Adulkasem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tawika","family":"Kaewchur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,6]]},"reference":[{"key":"1321_CR1","doi-asserted-by":"crossref","first-page":"14001","DOI":"10.1038\/boneres.2014.1","volume":"2","author":"RA Adler","year":"2014","unstructured":"Adler RA (2014) Osteoporosis in men: a review. Bone Res 2:14001","journal-title":"Bone Res"},{"issue":"2","key":"1321_CR2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/endrev\/bnab028","volume":"43","author":"PR Ebeling","year":"2022","unstructured":"Ebeling PR, Nguyen HH, Aleksova J, Vincent AJ, Wong P, Milat F (2022) Secondary osteoporosis. Endocr Rev 43(2):240\u2013313","journal-title":"Endocr Rev"},{"issue":"8","key":"1321_CR3","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nrrheum.2012.93","volume":"8","author":"K Walker-Bone","year":"2012","unstructured":"Walker-Bone K (2012) Recognizing and treating secondary osteoporosis. Nat Rev Rheumatol 8(8):480\u2013492","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"1321_CR4","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1530\/EJE-15-0118","volume":"173","author":"F Mirza","year":"2015","unstructured":"Mirza F, Canalis E (2015) Management of endocrine disease: secondary osteoporosis: pathophysiology and management. Eur J Endocrinol 173(3):R131\u2013R151","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1321_CR5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11657-022-01061-5","volume":"17","author":"CL Gregson","year":"2022","unstructured":"Gregson CL, Armstrong DJ, Bowden J, Cooper C, Edwards J, Gittoes NJL et al (2022) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 17(1):58","journal-title":"Arch Osteoporos"},{"key":"1321_CR6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.afos.2016.10.002","volume":"2","author":"T Songpatanasilp","year":"2016","unstructured":"Songpatanasilp T, Sritara C, Kittisomprayoonkul W, Chaiumnuay S, Nimitphong H, Charatcharoenwitthaya N et al (2016) Thai Osteoporosis Foundation (TOPF) position statements on management of osteoporosis. Osteoporos Sarcopenia 2:191\u2013207","journal-title":"Osteoporos Sarcopenia"},{"issue":"2","key":"1321_CR7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.afos.2023.06.001","volume":"9","author":"N Charatcharoenwitthaya","year":"2023","unstructured":"Charatcharoenwitthaya N, Jaisamrarn U, Songpatanasilp T, Kuptniratsaikul V, Unnanuntana A, Sritara C et al (2023) Summary of the Thai Osteoporosis Foundation (TOPF) Clinical Practice Guideline on the diagnosis and management of osteoporosis 2021. Osteoporos Sarcopenia 9(2):45\u201352","journal-title":"Osteoporos Sarcopenia"},{"key":"1321_CR8","volume-title":"Osteoporosis: assessing the risk of fragility fracture","author":"National Institute for Health and Care Excellence: Guidelines","year":"2017","unstructured":"National Institute for Health and Care Excellence: Guidelines (2017) Osteoporosis: assessing the risk of fragility fracture. London: National Institute for Health and Care Excellence (NICE) Copyright \u00a9 NICE 2019"},{"issue":"Suppl 1","key":"1321_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","volume":"26","author":"PM Camacho","year":"2020","unstructured":"Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A et al (2020) American Association of Clinical Endocrinologists\/American College Of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocr Pract 26(Suppl 1):1\u201346","journal-title":"Endocr Pract"},{"issue":"1","key":"1321_CR10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","volume":"30","author":"JA Kanis","year":"2019","unstructured":"Kanis JA, Cooper C, Rizzoli R, Reginster JY (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30(1):3\u201344","journal-title":"Osteoporos Int"},{"issue":"12","key":"1321_CR11","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s00198-012-2093-8","volume":"23","author":"A Diez-Perez","year":"2012","unstructured":"Diez-Perez A, Adachi JD, Agnusdei D, Bilezikian JP, Compston JE, Cummings SR et al (2012) Treatment failure in osteoporosis. Osteoporos Int 23(12):2769\u20132774","journal-title":"Osteoporos Int"},{"issue":"4","key":"1321_CR12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/jbmr.1496","volume":"27","author":"A D\u00edez-P\u00e9rez","year":"2012","unstructured":"D\u00edez-P\u00e9rez A, Olmos JM, Nogu\u00e9s X, Sosa M, D\u00edaz-Curiel M, P\u00e9rez-Castrill\u00f3n JL et al (2012) Risk factors for prediction of inadequate response to antiresorptives. J Bone Miner Res 27(4):817\u2013824","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1321_CR13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00198-015-3356-y","volume":"27","author":"HA Fink","year":"2016","unstructured":"Fink HA, Litwack-Harrison S, Taylor BC, Bauer DC, Orwoll ES, Lee CG et al (2016) Clinical utility of routine laboratory testing to identify possible secondary causes in older men with osteoporosis: the Osteoporotic Fractures in Men (MrOS) Study. Osteoporos Int 27(1):331\u2013338","journal-title":"Osteoporos Int"},{"key":"1321_CR14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s11657-015-0226-3","volume":"10","author":"K Johnson","year":"2015","unstructured":"Johnson K, Suriyaarachchi P, Kakkat M, Boersma D, Gunawardene P, Demontiero O et al (2015) Yield and cost-effectiveness of laboratory testing to identify metabolic contributors to falls and fractures in older persons. Arch Osteoporos 10:226","journal-title":"Arch Osteoporos"},{"issue":"10","key":"1321_CR15","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1210\/jc.2002-020275","volume":"87","author":"C Tannenbaum","year":"2002","unstructured":"Tannenbaum C, Clark J, Schwartzman K, Wallenstein S, Lapinski R, Meier D et al (2002) Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 87(10):4431\u20134437","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1321_CR16","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1007\/s00198-017-4131-z","volume":"28","author":"AS Mendis","year":"2017","unstructured":"Mendis AS, Ganda K, Seibel MJ (2017) Barriers to secondary fracture prevention in primary care. Osteoporos Int 28(10):2913\u20132919","journal-title":"Osteoporos Int"},{"key":"1321_CR17","doi-asserted-by":"crossref","first-page":"215145931982861","DOI":"10.1177\/2151459319828618","volume":"10","author":"GE Lee","year":"2019","unstructured":"Lee GE, Muffly S, Golladay GJ (2019) Management of fragility hip fractures: our institutional experience. Geriatr Orthop Surg Rehabil 10:2151459319828618","journal-title":"Geriatr Orthop Surg Rehabil"},{"issue":"1","key":"1321_CR18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11657-017-0356-x","volume":"12","author":"L Gani","year":"2017","unstructured":"Gani L, Reddy SK, Alsuwaigh R, Khoo J, King TFJ (2017) High prevalence of missed opportunities for secondary fracture prevention in a regional general hospital setting in Singapore. Arch Osteoporos 12(1):60","journal-title":"Arch Osteoporos"},{"issue":"4","key":"1321_CR19","doi-asserted-by":"crossref","first-page":"537","DOI":"10.4183\/aeb.2021.537","volume":"17","author":"K Nguyen","year":"2021","unstructured":"Nguyen K, Chen X, Hughes T, Hofflich H, Woods GN, McCowen KC (2021) Surprisingly few women with severe osteoporosis by bone densitometry undergo workup for secondary causes - a retrospective evaluation. Acta Endocrinol (Buchar) 17(4):537\u2013542","journal-title":"Acta Endocrinol (Buchar)"},{"issue":"9","key":"1321_CR20","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s00198-012-1958-1","volume":"23","author":"S Lekamwasam","year":"2012","unstructured":"Lekamwasam S, Adachi JD, Agnusdei D, Bilezikian J, Boonen S, Borgstr\u00f6m F et al (2012) A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int 23(9):2257\u20132276","journal-title":"Osteoporos Int"},{"issue":"12","key":"1321_CR21","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1007\/s00198-018-4650-2","volume":"29","author":"SL Ferrari","year":"2018","unstructured":"Ferrari SL, Abrahamsen B, Napoli N, Akesson K, Chandran M, Eastell R et al (2018) Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos Int 29(12):2585\u20132596","journal-title":"Osteoporos Int"},{"issue":"3","key":"1321_CR22","first-page":"85","volume":"39","author":"A Sheu","year":"2016","unstructured":"Sheu A, Diamond T (2016) Secondary osteoporosis. Aust Prescr 39(3):85\u201387","journal-title":"Aust Prescr"},{"issue":"7","key":"1321_CR23","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.3390\/nu14071483","volume":"14","author":"P Pludowski","year":"2022","unstructured":"Pludowski P, Takacs I, Boyanov M, Belaya Z, Diaconu CC, Mokhort T et al (2022) Clinical practice in the prevention, diagnosis and treatment of vitamin D deficiency: a Central and Eastern European Expert Consensus Statement. Nutrients 14(7):1483","journal-title":"Nutrients"},{"issue":"7","key":"1321_CR24","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911\u20131930","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1321_CR25","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR et al (2021) Consensus on diagnosis and management of Cushing's disease: a guideline update. Lancet Diabetes Endocrinol 9(12):847\u2013875","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"1321_CR26","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","volume":"99","author":"JP Bilezikian","year":"2014","unstructured":"Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C et al (2014) Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metabol 99(10):3561\u20133569","journal-title":"J Clin Endocrinol Metabol"},{"key":"1321_CR27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","volume":"92","author":"M Ketteler","year":"2017","unstructured":"Ketteler M, Block GA, Evenepoel P et al (2017) Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. Kidney Int 92:26\u201336","journal-title":"Kidney Int"},{"issue":"10","key":"1321_CR28","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.amjmed.2010.02.028","volume":"123","author":"G Mazziotti","year":"2010","unstructured":"Mazziotti G, Canalis E, Giustina A (2010) Drug-induced osteoporosis: mechanisms and clinical implications. Am J Med 123(10):877\u2013884","journal-title":"Am J Med"},{"issue":"2","key":"1321_CR29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.maturitas.2009.08.003","volume":"65","author":"LT Shuster","year":"2010","unstructured":"Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA (2010) Premature menopause or early menopause: long-term health consequences. Maturitas 65(2):161\u2013166","journal-title":"Maturitas"},{"issue":"1","key":"1321_CR30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/M14-0697","volume":"162","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KG (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med 162(1):55\u201363","journal-title":"Ann Intern Med"},{"issue":"4","key":"1321_CR31","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1055\/s-0038-1634008","volume":"44","author":"P Royston","year":"2005","unstructured":"Royston P, Sauerbrei W (2005) Building multivariable regression models with continuous covariates in clinical epidemiology--with an emphasis on fractional polynomials. Methods Inf Med 44(4):561\u2013571","journal-title":"Methods Inf Med"},{"issue":"12","key":"1321_CR32","doi-asserted-by":"crossref","first-page":"e10417","DOI":"10.1002\/jbm4.10417","volume":"4","author":"A Giustina","year":"2020","unstructured":"Giustina A, Bouillon R, Binkley N, Sempos C, Adler RA, Bollerslev J et al (2020) Controversies in vitamin D: a statement from the Third International Conference. JBMR Plus 4(12):e10417","journal-title":"JBMR Plus"},{"issue":"2","key":"1321_CR33","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.nut.2009.12.001","volume":"27","author":"LO Chailurkit","year":"2011","unstructured":"Chailurkit LO, Kruavit A, Rajatanavin R (2011) Vitamin D status and bone health in healthy Thai elderly women. Nutrition 27(2):160\u2013164","journal-title":"Nutrition"},{"key":"1321_CR34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2318-12-49","volume":"12","author":"A Kruavit","year":"2012","unstructured":"Kruavit A, Chailurkit LO, Thakkinstian A, Sriphrapradang C, Rajatanavin R (2012) Prevalence of vitamin D insufficiency and low bone mineral density in elderly Thai nursing home residents. BMC Geriatr 12:49","journal-title":"BMC Geriatr"},{"issue":"2","key":"1321_CR35","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1359\/jbmr.090728","volume":"25","author":"M Priemel","year":"2010","unstructured":"Priemel M, von Domarus C, Klatte TO, Kessler S, Schlie J, Meier S et al (2010) Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res 25(2):305\u2013312","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1321_CR36","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19(4):385\u2013397","journal-title":"Osteoporos Int"},{"key":"1321_CR37","doi-asserted-by":"crossref","unstructured":"Subramaniam S, Ima-Nirwana S, Chin KY (2018) Performance of osteoporosis self-assessment tool (OST) in predicting osteoporosis-a review. Int J Environ Res Public Health 15(7)","DOI":"10.3390\/ijerph15071445"},{"issue":"1","key":"1321_CR38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","volume":"71","author":"A Levin","year":"2007","unstructured":"Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA et al (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71(1):31\u201338","journal-title":"Kidney Int"},{"issue":"1","key":"1321_CR39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s40618-017-0753-4","volume":"41","author":"GR Williams","year":"2018","unstructured":"Williams GR, Bassett JHD (2018) Thyroid diseases and bone health. J Endocrinol Invest 41(1):99\u2013109","journal-title":"J Endocrinol Invest"},{"issue":"20","key":"1321_CR40","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1001\/jama.2015.5161","volume":"313","author":"MR Blum","year":"2015","unstructured":"Blum MR, Bauer DC, Collet TH, Fink HA, Cappola AR, da Costa BR et al (2015) Subclinical thyroid dysfunction and fracture risk: a meta-analysis. Jama 313(20):2055\u20132065","journal-title":"Jama"},{"key":"1321_CR41","doi-asserted-by":"crossref","first-page":"873820","DOI":"10.3389\/fendo.2022.873820","volume":"13","author":"S Zhu","year":"2022","unstructured":"Zhu S, Pang Y, Xu J, Chen X, Zhang C, Wu B et al (2022) Endocrine regulation on bone by thyroid. Front Endocrinol (Lausanne) 13:873820","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"1321_CR42","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S2213-8587(21)00285-0","volume":"10","author":"B Biondi","year":"2022","unstructured":"Biondi B, Cappola AR (2022) Subclinical hypothyroidism in older individuals. Lancet Diabetes Endocrinol 10(2):129\u2013141","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"1321_CR43","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1515\/cclm-2022-0177","volume":"60","author":"J Favresse","year":"2022","unstructured":"Favresse J, Schiettecatte J, Wolff F, Cotton F, Elsen M, Eucher C et al (2022) Two-site evaluation of the Roche Elecsys vitamin D total III assay. Clin Chem Lab Med 60(10):1598\u20131606","journal-title":"Clin Chem Lab Med"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-023-01321-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-023-01321-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-023-01321-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T13:37:21Z","timestamp":1704375441000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-023-01321-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,6]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1321"],"URL":"https:\/\/doi.org\/10.1007\/s11657-023-01321-y","relation":{},"ISSN":["1862-3514"],"issn-type":[{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,6]]},"assertion":[{"value":"14 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Pitchaporn Phudphong, Mattabhorn Phimphilai, Worapaka Manosroi, Nath Adulkasem, and Tawika Kaewchur declare that the research was conducted in the absence of any commercial or financial relationships that could be\u00a0construed as potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"114"}}